Brandicourt joins Alnylam's board: plus Bayer, Jazz, Halozyme, Arena, Aurinia, Adverum, Neoleukin, Centogene, Epirium, Insilico, Nouscom, Eloxx, Nordic, Summit,

RNAi therapeutics company Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) said Olivier Brandicourt will join its board. Brandicourt, who retired as CEO of Sanofi (Euronext:SAN; NASDAQ:SNY) last year, also plans to join Blackstone Group as a senior adviser.

Bayer AG (Xetra:BAYN) said Norbert Winkeljohann will succeed Werner Wenning as chairman, effective April 28. Along with being on the pharma's board, Winkeljohann is chairman of PricewaterhouseCoopers Europe SE.

Sleep disorder

Read the full 640 word article

How to gain access

Continue reading with a
two-week free trial.